CRIPTO3 and Alzheimer disease: The value of monitoring CR3 expression has been shown in acute myeloid leukemia (315, 316), childhood acute lymphoblastic leukemia (317), neonatal sepsis (318), inflammatory lung disease (319), metabolic syndrome (320), Alzheimer’s disease (321), and gastric cancer.